FDA Inspection 988639 — Samson Pharmaceuticals, Inc

Samson Pharmaceuticals, Inc — FEI 3005644727

The FDA completed an inspection of Samson Pharmaceuticals, Inc on March 25, 2016 in Commerce, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 25, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Commerce, CA (United States)